EuBiologics Co., Ltd. (206650) Stock Forecast & Price Target
206650 Analyst Ratings
There are no analyst ratings in the last 3 months.
206650 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
No analyst ratings match these filters.
Stocks with the Highest Top Analyst Consensus in the General Sector
206650 Financial Forecast
ConsensusKRW 204.25
206650 Earnings Forecast
Next quarter’s earnings estimate for 206650 is KRW 204.25 with a range of ― to ―. The previous quarter’s EPS was KRW 204.25. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
HighKRW 47.9B
ConsensusKRW 47.9B
LowKRW 47.9B
206650 Sales Forecast
Next quarter’s sales forecast for 206650 is KRW 47.90B with a range of KRW 47.90B to KRW 47.90B. The previous quarter’s sales results were KRW 33.22B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
206650 Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about EuBiologics Co., Ltd.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of EuBiologics Co., Ltd.?
To buy shares of KR:206650, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
